Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aplastic anemia: pathogenesis and treatment.

A Bacigalupo, G Piaggio, M T Van Lint

    Onkologie
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).

    Oral oncology·2026
    Same author

    Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapy.

    ESMO open·2025
    Same author

    KEYNOTE-689: A step forward or a leap of faith in resectable LA-HNSCC?

    Oral oncology·2025
    Same author

    Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis.

    Bone marrow transplantation·2023
    Same author

    Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation.

    Annals of hematology·2022
    Same author

    Chemo- immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?

    Oral oncology·2022

    Treatment for severe aplastic anemia (SAA) shows promising results. Hematopoietic stem cell transplantation (HSCT) survival rates are encouraging, but donor availability remains a challenge for this blood disorder.

    Area of Science:

    • Hematology
    • Transplantation Medicine
    • Immunology

    Background:

    • Severe aplastic anemia (SAA) is a life-threatening condition.
    • Treatment options for SAA have evolved significantly.
    • Historical data on SAA treatment outcomes are crucial for future strategies.

    Purpose of the Study:

    • To review the treatment of severe aplastic anemia in Europe from 1970 to 1986.
    • To evaluate the outcomes of different SAA treatment modalities.
    • To discuss the role of hematopoiesis regulation in SAA treatment.

    Main Methods:

    • Retrospective review of 487 patients undergoing HLA-identical bone marrow transplantation (BMT).
    • Analysis of outcomes for 45 patients receiving non-HLA identical BMT.
    • Evaluation of results for 509 patients treated with immunosuppression (IS).

    Related Experiment Videos

    Main Results:

    • HLA-identical BMT demonstrated encouraging survival rates of approximately 65%.
    • Outcomes for non-HLA identical BMT were dependent on the degree of HLA mismatch.
    • Immunosuppression therapy resulted in a 50% survival rate for SAA patients.

    Conclusions:

    • HLA-identical BMT is an effective treatment for SAA when a matched donor is available.
    • Donor availability remains a significant limitation for BMT in SAA treatment.
    • Further research into in vitro hematopoiesis may offer new therapeutic avenues for SAA.